Carregant...
Development of a High-Flow Nasal Cannula and Pharmaceutical Aerosol Combination Device
Background: Aerosol drug delivery to the lungs is known to be very inefficient during all forms of noninvasive ventilation, especially when the aerosol is administered simultaneously with high-flow nasal cannula (HFNC) therapy. The objective of this study was to develop a new combination device base...
Guardat en:
| Publicat a: | J Aerosol Med Pulm Drug Deliv |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Mary Ann Liebert, Inc., publishers
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6685196/ https://ncbi.nlm.nih.gov/pubmed/30855199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2018.1488 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|